Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Belatacept-based immunosuppression after kidney transplantation allows for better renal function compared to cyclosporine, with similar graft and patient survival, phase III trial results…
NEW YORK (Reuters Health) – Intensive insulin therapy in type 1 diabetics reduces their risks of neuropathy and retinopathy over the long-term, according to two papers published online…
NEW YORK (Reuters Health) – Prophylactic antibiotics may improve survival of burn patients, a meta-analysis suggests, although the authors acknowledge that the quality of the supporting data is…
NEW YORK (Reuters Health) – In postmenopausal women with osteoporosis, the selective estrogen-receptor modulator lasofoxifene cuts the risks of fractures, estrogen-receptor-positive breast cancer, coronary disease, and stroke, the…
NEW YORK (Reuters Health) – In patients with HIV and tuberculosis (TB) whose CD4 cell counts are below 500/mm3, mortality is increased if antiretroviral therapy is delayed until…
NEW YORK (Reuters Health) – During early resuscitation in severe sepsis, lactate clearance can indicate tissue oxygen delivery as effectively as central venous oxygen saturation, with considerably less…
NEW YORK (Reuters Health) – Beta blockade before computed tomographic coronary angiography (CTA) can improve image quality, but a substantial number of patients who require CTA have contraindications…
NEW YORK (Reuters Health) – Survival of extremely premature infants (less than 26 weeks’ gestation) can’t be predicted by appearance at birth and early response to resuscitation, according…
NEW YORK (Reuters Health) – An implantable cardioverter-defibrillator (ICD) should be considered when patients with long QT syndrome (LQTS) have syncope while on beta-blockers. That’s according to authors…
NEW YORK (Reuters Health) – Daclizumab added to ongoing interferon-beta treatment further decreases multiple sclerosis disease activity, according to a multicenter phase II trial reported online February 16…
